Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
GLOBAL PHARMA GROUP from Hasselt, company number BE0849471758, closed financial year 2025 with a result of € 17,441 after tax. For that financial year GLOBAL PHARMA GROUP recorded a gross margin of € 31,213 and equity of € -623,393. Compared with financial year 2024, the result moved from € -530,747 to € 17,441. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ -623,393
▲ € 17,441 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 17,441
▲ still € 530,747 loss in 2024
Profit after tax over the fiscal year.
€ 19,716
▼ 79% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -629,603.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 12,000
▼ 82% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -58,068 | € 105,796 | € -373,910 | € 31,213 | ▲ € 405,123 |
| Profit after taxes | € -63,167 | € -38,187 | € -530,747 | € 17,441 | ▲ € 548,189 |
| Equity | € -71,899 | € -110,086 | € -640,834 | € -623,393 | ▲ € 17,441 |
| Total debts | € 1,213,314 | € 3,919,914 | € 1,709,209 | € 993,385 | ▼ 42% |
| Cash | € 5,997 | € 526 | € 94,140 | € 19,716 | ▼ 79% |
| Retained profit | € -78,109 | € -116,296 | € -647,044 | € -629,603 | ▲ € 17,441 |
| Bank debt | € 681,598 | € 2,974,999 | € 526,800 | € 0 | ▼ 100% |
| Balance sheet total | € 1,141,415 | € 3,809,828 | € 1,068,375 | € 369,993 | ▼ 65% |
Key figures of GLOBAL PHARMA GROUP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GLOBAL PHARMA GROUP?
What happened at GLOBAL PHARMA GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 17,441. Source: NBB ↗
- Minot BV became a director. NBB
- Darwin NV became a director. NBB
- New establishment in Hasselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,167 loss in 2022 to € 17,441 profit in 2025.
Best year ever: 2025, with € 17,441 profit.
A new publication or filing at GLOBAL PHARMA GROUP? We notify you, reason included.
Follow GLOBAL PHARMA GROUPDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind GLOBAL PHARMA GROUP are Minot BV and Darwin NV. Minot BV is also behind APOTHEEK MEES HASSELT and APOTHEEK VAN GORP. Darwin NV is also behind APOTHEEK ELZEDORP, MEES MANAGEMENT APOTHEEK, Columbus Group, ANTWERP PHARMACIES and MV-Management.
Directors
According to the 2025 annual accounts
Director · represented by Van Gorp Ann
Also active at: APOTHEEK MEES HASSELT, APOTHEEK VAN GORP
since 2021
Director · represented by Mees Joris
Also active at: APOTHEEK ELZEDORP, MEES MANAGEMENT APOTHEEK, Columbus Group, ANTWERP PHARMACIES, MV-Management, Life Planning, DSA HOLDING, GLOBUS Q +4 more
since 2021
Establishments
Establishment units
Physical locations of this company
Luikersteenweg 193
3500 Hasselt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0849.471.758
- VAT number
- BE 0849.471.758
- Registered office
- Luikersteenweg 193, 3500 Hasselt
- Names & denominations
- GLOBAL PHARMA GROUP
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 October 2012
- Peppol
- Active · Active since 1 Aug 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Diverse ondersteunende activiteiten ten behoeve van voorzieningen
Activiteiten van hoofdkantoren
Overige dienstverlenende activiteiten op het gebied van informatie
Overige zakelijke dienstverlening, neg
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.